Definitive Contract 75N91023C00023
Award Date 8/15/23
Potential Completion Date 2/14/25
Potential Value $455K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Lexington, KY 40513, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $455,000 firm fixed-price Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Carina Medical LLC, a minority-owned small business. The contract supports research and development of artificial intelligence (AI)-aided imaging technologies for cancer prevention, diagnosis, and monitoring. This work aligns with the NCI's mission and the SBIR program's goals of stimulating...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $2 million firm fixed price definitive contract to Carina Medical LLC as a total small business set aside. The contract is for Fiscal Year 2023 Small Business Innovation Research Topic 402 Phase II efforts to enhance the performance of artificial intelligence for lymph node detection, segmentation and measurements in multi-modality medical imaging, and to develop additional...
- This is a $455,000 firm fixed price contract awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) at the Department of Health and Human Services (HHS). The contract was awarded to Mrimath LLC, a small disadvantaged, woman-owned limited liability company, for a Small Business Innovation Research (SBIR) Phase I project related to Artificial Intelligence-aided imaging for cancer prevention, diagnosis, and monitoring. The contract has a...
- This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Neuralrad LLC, a small business, for $454,559.00. The contract was awarded under the SBIR (Small Business Innovation Research) program to support the development of "Quantitative Imaging Software Tools for Cancer Diagnosis and Treatment Planning" as described in the original solicitation. This Phase I SBIR contract has a period of performance from...
- This is a $1,990,308.00 Firm Fixed Price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency, to Neuralrad LLC, a small business, for the development of quantitative imaging software tools for cancer diagnosis and treatment planning. The contract is set aside for small businesses and has an ultimate completion date of August 27, 2026. The software tools are being developed under the NCI's Small Business Innovation Research (SBIR) program, specifically under...
- This $2,399,183 firm-fixed-price SBIR Phase I contract was awarded by the National Cancer Institute (NCI) to Radiologics, Inc., a small business, to conduct research and development on cancer imaging tools and image de-identification software. The contract is part of the NCI's SBIR program, which aims to stimulate technological innovation and increase private sector commercialization of innovations derived from federal R&D. The contract has a period of performance through January 2024 and is...
- This is a $398,604.00 Small Business Innovation Research (SBIR) Program Phase I contract awarded to Infotech Soft, Inc. (a woman-owned for-profit organization) by the National Cancer Institute. The contract is for the development of quantitative imaging software tools to assist with cancer diagnosis and treatment planning. The contract is a definitive, firm fixed-price agreement, indicating a well-defined scope of work. This SBIR award is part of the National Cancer Institute's efforts to...
- This definitive contract from the Department of Health and Human Services' National Institutes of Health National Cancer Institute awards $377,530 to Gradient Health, Inc., doing business as Gradient Health, for TOPIC 454 - SOFTWARE TO EVALUATE ARTIFICIAL INTELLIGENCE/MACHINE LEARNING MEDICAL DEVICES IN ONCOLOGY SETTINGS. The prime contractor will perform work in Raleigh, North Carolina under a firm fixed price contract lasting from August 15, 2023 to August 14, 2024. This award stems from a...
- This is a firm fixed-price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency, to Digital Artefacts LLC, a minority-owned, small disadvantaged business. The contract is for the development of a "CANCER PATIENT COGNITIVE ASSESSMENT PLATFORM" under TOPIC 343, with a ceiling value of $216,431.00 and a completion date of September 18, 2017. The contract does not have a set-aside designation. As the NCI is the funding agency, this contract supports the...
- This $399,951 firm-fixed-price definitive contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to the small business Care Progress LLC. The contract supports the development of "BIOMARKERAWARE: A NOVEL SYSTEM TO IMPROVE PRECISION ONCOLOGY" under the NCI's Small Business Innovation Research (SBIR) program, which is a set-aside for small businesses. Care Progress LLC, a for-profit limited liability company, has previously...
This $455,000 firm fixed price contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Carina Medical LLC, a minority-owned small business. The contract, set aside for small businesses, is for the development of software to evaluate artificial intelligence/machine learning medical devices in oncology settings. Carina Medical has a history of federal contracts and grants from the NCI and NIH, totaling over $8 million, to advance AI-enabled technologies for cancer diagnosis, treatment planning, and monitoring. This specific effort aims to create software tools to assess the safety and effectiveness of AI/ML-based medical devices used in oncology applications.
Generated 9/20/24, 9:03 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Vendor Address Change | $0 | 9/19/24 | |
| P00002 | Other Administrative Action | $0 | 8/13/24 | |
| P00001 | Exercise an Option | $55.0k | 2/15/24 | |
| Not listed | Not listed | $400.0k | 8/9/23 |